Exploring new treatment avenues has become crucial as mental health challenges such as depression and PTSD continue impacting ...

Silo Pharma (SILO) announced the filing of a provisional patent application with the U.S. Patent and Trademark Office. This application, ...

"Silo Pharma's intellectual property strategy continues to be a cornerstone of our growth,” said Eric Weisblum, CEO of Silo ...

This announcement is based on a press release statement from Silo Pharma. With a current ratio of 7.9, the company maintains strong liquidity to fund its development pipeline, though analysts tracked ...

IRVINE, Calif., Jan. 9, 2025 /PRNewswire/ -- GATC Health is redefining the landscape of Post-Traumatic Stress Disorder (PTSD) treatment and drug discovery through its proprietary Multiomics ...

A researcher from the Providence Veteran's Association recently made the trip to Ukraine to train doctors there on a non-medicinal treatment for PTSD. It's called transcranial magnetic stimulation.

Following receipt of the Notice of Allowance, Silo filed the final issue paperwork, paid the issue fees, and expects formal issuance of the patent in the next 90 days The patent, when formally ...

OLYMPIA, Wash.-Legislators in Olympia are considering a bill to provide PTSD treatment to county coroners and medical ...

an intranasal treatment targeting post-traumatic stress disorder. The patent includes newly added claims to U.S. Patent 11,491,120, which was issued to Silo in February 2023. Silo holds an ...